IMAC · Imac Holdings, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.2K | - | $1.5K | - | $56.3K | $15.8K | - | - | $3.79M | $5.03M |
| Cost of Revenue | $123.9K | $102.3K | $103.2K | - | $122.1K | $72.0K | - | - | - | - |
| Gross Profit | ($102.7K) | ($102.3K) | ($101.7K) | - | ($65.8K) | ($56.3K) | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $1.75M | $1.87M | $2.09M | - | $1.93M | $1.35M | $258.4K | - | $1.13M | $886.6K |
| Total Operating Expenses | $2.50M | $1.87M | $2.09M | - | $1.93M | $1.35M | $408.6K | - | $4.46M | $2.72M |
| D&A | $52.0K | $52.0K | $52.2K | - | $52.0K | $35.0K | $0 | - | $77.2K | $119.8K |
| Operating Income | ($2.60M) | ($1.97M) | ($2.19M) | - | ($2.00M) | ($1.40M) | ($408.6K) | - | ($2.90M) | ($1.38M) |
| Interest Expense | $466.6K | $148.2K | $11.5K | - | $106.6K | $12.0K | $40.5K | - | $71.8K | $22.4K |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($3.08M) | ($2.12M) | ($2.20M) | - | ($2.20M) | ($1.38M) | ($407.2K) | - | ($2.86M) | ($1.40M) |
| EPS - Basic | ($1.15) | ($0.89) | ($1.08) | - | ($1.38) | ($1.72) | ($0.35) | - | ($2.63) | ($0.04) |
| EPS - Diluted | ($1.15) | ($0.89) | ($1.08) | - | ($1.38) | ($1.72) | ($0.35) | - | ($2.63) | ($0.07) |
Balance Sheet
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.1K | $42.7K | $30.9K | $504.2K | $221.5K | $890.6K | $17.5K | $221.5K | $224.6K | $247.0K |
| Accounts Receivable | - | - | - | $28.0K | $41.7K | $15.8K | $731.1K | $731.1K | $736.3K | $678.6K |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $310.1K | $277.1K | $287.6K | $684.3K | $510.7K | $1.21M | $910.8K | $1.14M | $2.07M | $1.28M |
| Total Assets | $310.1K | $1.08M | $1.14M | $1.59M | $1.47M | $2.22M | $910.8K | $1.14M | $4.26M | $4.64M |
| Current Liabilities | $13.29M | $10.90M | $8.77M | $7.98M | $6.27M | $4.52M | $2.15M | $1.90M | $2.46M | $3.92M |
| Long-term Debt | - | - | - | - | - | - | - | - | $44.1K | $74.6K |
| Total Liabilities | - | - | - | $7.98M | - | - | $2.15M | $1.90M | $3.24M | $5.00M |
| Stockholders' Equity | ($12.98M) | ($9.83M) | ($7.63M) | ($6.39M) | ($4.04M) | ($2.29M) | ($1.24M) | ($752.6K) | $11.55M | $14.09M |
| Retained Earnings | ($72.38M) | ($69.30M) | ($67.18M) | ($64.98M) | ($59.93M) | ($57.73M) | ($56.35M) | ($55.94M) | ($54.53M) | ($51.62M) |
Cash Flow
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($1.03M) | - | - | - | ($202.3K) | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | $560.0K | - | - | - | ($1.7K) | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | -483.7% | - | -6779.1% | - | -116.8% | -357.2% | - | - | - | - |
| Operating margin | -12258.4% | - | -145926.7% | - | -3545.5% | -8901.2% | - | - | -76.5% | -27.4% |
| EBITDA margin | -12013.4% | - | -142447.2% | - | -3453.1% | -8679.0% | - | - | -74.5% | -25.1% |
| Net margin | -14505.6% | - | -146657.9% | - | -3915.9% | -8783.5% | - | - | -75.5% | -27.9% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 8249.7% | - | 139147.6% | - | 3428.6% | 8544.1% | - | - | 29.8% | 17.6% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -992.9% | -196.8% | -192.9% | - | -150.2% | -62.2% | -44.7% | - | -67.0% | -30.2% |
| Return on equity | 23.7% | 21.6% | 28.8% | - | 54.6% | 60.3% | 32.9% | - | -24.7% | -10.0% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.02 | 0.03 | 0.03 | 0.09 | 0.08 | 0.27 | 0.42 | 0.60 | 0.84 | 0.33 |
| Quick ratio | 0.02 | 0.03 | 0.03 | 0.09 | 0.08 | 0.27 | 0.42 | 0.60 | 0.84 | 0.33 |
| Cash ratio | 0.00 | 0.00 | 0.00 | 0.06 | 0.04 | 0.20 | 0.01 | 0.12 | 0.09 | 0.06 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | 0.00 | 0.01 |
| Debt / Assets | - | - | - | - | - | - | - | - | 0.01 | 0.02 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -5.6x | -13.3x | -190.9x | - | -18.7x | -117.3x | -10.1x | - | -40.3x | -61.8x |
| Equity multiplier | -0.02 | -0.11 | -0.15 | -0.25 | -0.36 | -0.97 | -0.74 | -1.52 | 0.37 | 0.33 |
| Liabilities / Assets | - | - | - | 5.02 | - | - | 2.36 | 1.66 | 0.76 | 1.08 |
| Efficiency | ||||||||||
| Asset turnover | 0.07 | - | 0.00 | - | 0.04 | 0.01 | - | - | 0.89 | 1.08 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | 270d | 365d | - | - | 71d | 49d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -62.3% | - | - | - | -98.5% | -99.7% | - | - | 0.0% | 0.0% |
| Revenue CAGR (3y) | -82.2% | - | -92.7% | - | -74.7% | -83.4% | - | - | 2.9% | 25.1% |
| Revenue CAGR (5y) | -63.9% | - | -78.6% | - | -58.1% | -52.3% | - | - | - | - |
| Gross profit growth (YoY) | -56.1% | -81.9% | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -30.3% | -40.7% | -435.7% | - | 31.1% | -1.5% | 88.9% | - | 54.3% | 23.3% |
| Net income growth (YoY) | -39.6% | -53.3% | -440.2% | - | 22.9% | 1.4% | 89.0% | - | 54.9% | 23.9% |
| EPS growth (YoY) | 16.7% | 48.3% | -208.6% | - | 47.5% | -2357.1% | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -221.4% | -328.2% | -515.9% | -749.5% | - | - | - | - | 0.0% | 0.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Product / service
$14.39M totalHealth Care Patient Service$14.16M · 98.5%
Management Service$216.1K · 1.5%
Others Income$6.1K · 0.0%
Peer comparison
Same SIC group: Services-Specialty Outpatient Facilities, NEC
Comparing IMAC Holdings against the 5 most active filers in the same SIC group.